for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Valeant's deceptive carrot

Posted

June 2 - Jeffrey Goldfarb and Rob Cyran discuss the new $54 bln bid for Allergan. Going hostile is one stick. More money is the carrot, but the offer is still mostly in Valeant stock.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up